Gladstone Institutional Advisory’s Aurinia Pharmaceuticals AUPH Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-17,300	Closed	-$190K	–	640
2023 Q1	$190K	Sell	17,300 -2,500	-13%	-$22K	0.01%	616
2022 Q4	$85.5K	Sell	19,800 -33,300	-63%	-$193K	0.01%	621
2022 Q3	$399K	Sell	53,100 -19,300	-27%	-$167K	0.03%	434
2022 Q2	$728K	Sell	72,400 -7,000	-9%	-$78.3K	0.06%	336
2022 Q1	$983K	Sell	79,400 -23,200	-23%	-$359K	0.07%	295
2021 Q4	$2.35M	Buy	102,600 +26,100	+34%	+$618K	0.18%	154
2021 Q3	$1.69M	Sell	76,500 -12,800	-14%	-$203K	0.17%	162
2021 Q2	$1.16M	Hold	89,300	–	–	0.14%	175
2021 Q1	$1.16M	Sell	89,300 -2,450	-3%	-$35.5K	0.18%	126
2020 Q4	$1.27M	Buy	91,750 +19,000	+26%	+$277K	0.25%	88
2020 Q3	$1.07M	Buy	72,750 +10,850	+18%	+$157K	0.26%	90
2020 Q2	$1.01M	Buy	61,900 +6,998	+13%	+$112K	0.26%	83
2020 Q1	$797K	Buy	+54,902	New	+$968K	0.21%	102